Merck, Pfizer announce phase III JAVELIN Gastric 300 trial in patients with pre-treated advanced gastric cancer fails to meet primary endpoint
Merck and Pfizer have announced that the phase III JAVELIN Gastric 300 trial did not meet its primary endpoint of superior overall survival (OS)...
Nippon Chemiphar announces positive results from phase-1 trial of NC-2500, a novel XOR inhibitor
Nippon Chemiphar has announced that the phase-1 clinical trial of NC-2500, a novel xanthine oxidoreductase (XOR) inhibitor, was completed, indicating that it has potential...
Navitas Brings End-to-End R&D Solutions to the Generic Drug Industry
Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver "first to file" results to generic drug companies around the globe,...
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
Capricor Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to conduct a new clinical...
Aimovig Phase 3 STRIVE Data Published In The New England Journal Of Medicine Demonstrate Significant, Sustained Efficacy In Migraine Prevention
Amgen announced that the New England Journal of Medicine (NEJM) published positive results from the six-month Phase 3 STRIVE study evaluating Aimovig™ (erenumab) versus...
Merck Receives FDA Approval for ISENTRESS , in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection
Merck , known as MSD outside the United States and Canada announced that the U.S. FDA has approved ISENTRESS® (raltegravir), the company’s integrase inhibitor,...
Surge in RNAscope and BaseScope Assay publications now includes pharma, biotech and new research areas – and use as a core assay
Advanced Cell Diagnostics (ACD), a Bio-Techne brand, is celebrating a milestone in the adoption of its RNAscope® in situ hybridization (ISH) technology. Reaching 1,000...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...